Further, CAFs increase ECM secretion, creating a physical barrier to prevent immune cell infiltration and migration within the tumor, based on the secretion of chemokine CXCL12, which is known to promote angiogenesis and tumor growth. Here, CXCL12 is linked to neoplasm.